Invesco Ltd. Puma Biotechnology, Inc. Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 37,631 shares of PBYI stock, worth $123,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,631
Previous 19,924
88.87%
Holding current value
$123,805
Previous $60,000
85.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PBYI
# of Institutions
116Shares Held
30.9MCall Options Held
32.7KPut Options Held
200-
Acorn Capital Advisors, LLC New York, NY3.94MShares$13 Million8.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$12.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$11.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$6.61 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$6.02 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $150M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...